Corsee D. Sanders net worth and biography

Corsee Sanders Biography and Net Worth

Director of BeOne Medicines

Corsee Sanders, Ph.D., joined our Board of Directors in 2020. Dr. Sanders has been a member of the Audit Committee since August 2020.

Most recently, Dr. Sanders served as Strategic Advisor to the Office of the Celgene Chief Medical Officer and Transition Advisor to Bristol Myers Squibb. Prior to that, she was a member of the Executive Committee at Juno Therapeutics and served as Executive Vice President of Development Operations. Dr. Sanders previously held several senior leadership positions at Genentech/Roche, including Global Head of Biometrics and Global Head of Clinical Operations. She was Co-Chair of the Roche-Chugai Joint Portfolio Management Committee.

Dr. Sanders currently serves on the Board of Trustees for the Fred Hutchinson Cancer Research Center and on the Board of Directors of Molecular Templates Inc., Legend Biotech Corporation, and AltruBio (formerly AbGenomics) Inc.

Dr. Sanders earned a B.S. and an M.S. in statistics from the University of the Philippines and an M.A. and a Ph.D. in statistics from the Wharton Doctoral Program at the University of Pennsylvania.

What is Corsee D. Sanders' net worth?: The estimated net worth of Corsee D. Sanders is at least $5.09 million as of June 20th, 2025. Dr. Sanders owns 15,344 shares of BeOne Medicines stock worth more than $5,085,002 as of December 5th. This net worth estimate does not reflect any other investments that Dr. Sanders may own. Learn More about Corsee D. Sanders' net worth.
How do I contact Corsee D. Sanders?: The corporate mailing address for Dr. Sanders and other BeOne Medicines executives is C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, E9, KY1-1108. BeOne Medicines can also be reached via phone at 13459494123 and via email at [email protected]. Learn More on Corsee D. Sanders' contact information.
Has Corsee D. Sanders been buying or selling shares of BeOne Medicines?: During the last quarter, Corsee D. Sanders has sold $895,544.30 of BeOne Medicines stock. Most recently, Corazon (Corsee) D. Sanders sold 2,627 shares of the business's stock in a transaction on Wednesday, November 26th. The shares were sold at an average price of $340.90, for a transaction totalling $895,544.30. Learn More on Corsee D. Sanders' trading history.
Who are BeOne Medicines' active insiders?: BeOne Medicines' insider roster includes Chan Lee (SVP), John Oyler (CEO), Aaron Rosenberg (CFO), Corsee Sanders (Director), Corsee Sanders (Director), Lai Wang (Global Head of R&D), Lai Wang (Insider), Xiaodong Wang (Insider), and Xiaobin Wu (COO). Learn More on BeOne Medicines' active insiders.
Are insiders buying or selling shares of BeOne Medicines?: In the last twelve months, insiders at the sold shares 51 times. They sold a total of 1,475,419 shares worth more than $391,016,020.22. The most recent insider tranaction occured on November, 26th when Director Corazon (Corsee) D Sanders sold 2,627 shares worth more than $895,544.30. Insiders at BeOne Medicines own 6.6% of the company. Learn More about insider trades at BeOne Medicines.
Information on this page was last updated on 11/26/2025.

Corsee D. Sanders Insider Trading History at BeOne Medicines

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/26/2025	Sell	2,627	$340.90	$895,544.30
9/5/2025	Sell	2,665	$337.00	$898,105.00

Corsee D. Sanders Buying and Selling Activity at BeOne Medicines

BeOne Medicines Company Overview

BeOne Medicines Ltd. is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. The firm portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. The company was founded by Xiao Dong Wang and John V. Oyler on October 28, 2010 and is headquartered in Basel, Switzerland.

Today's Range

Now: $331.40

$330.98

$340.98

50 Day Range

MA: $332.91

$308.22

$377.47

2 Week Range

Now: $331.40

$170.99

$385.22

Volume

239,751 shs

Average Volume

310,848 shs

Market Capitalization

$39.28 billion

P/E Ratio

649.80

Dividend Yield

N/A

Beta

0.45